Company: MBIO
Filing Date: 2025-04-01
Form Type: 424B3
Source: 0001104659-25-030657
Chunk: 116

Company: MUSTANG BIO, INC.
Filing Date: 2025-04-01
Form: 424B3
Chunk 116
---
 2024 Warrants had an exercise price of $11.85 per share. Pursuant to the Inducement Letter, the Investor agreed to exercise
in full, for cash, the Series A-3 Warrants (the “Existing Warrants”) at the exercise price of $11.85 per share in consideration
for our agreement to issue in a private placement (x) new Series B-1 Warrants to purchase337,552
shares of common stock and (y) new Series B-2 Warrants to purchase337,552 shares of
common stock (collectively, the “New Warrants”). In addition, we issued to Wainwright or its designees placement agent warrants
to purchase 20,251 shares of common stock. The placement agent warrants have the same terms as the
Series B-1 Warrants, except that the placement agent warrants have an exercise price equal to $14.815 per share. The transactions
contemplated by the Inducement Letter closed on October 25, 2024. We received aggregate gross proceeds of approximately $4.0 million
from the exercise of the Existing Warrants by the investor, before deducting placement agent fees and other expenses payable by us. The
New Warrants were offered and sold in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities
Act. The investor also represented that it qualified as an “accredited investor” within the meaning of Rule 501 of Regulation
D.

​

Issuer Purchases of Equity Securities

​

None.

​

Item 6. Reserved

​

Item 7. Management’s Discussion and Analysis of the Results of Operations

​

Statements in the following discussion and throughout this Form 10-K that are not historical in nature are “forward-looking statements.” You can identify forward-looking statements by the use of words such as “expect,” “anticipate,” “estimate,” “may,” “will,” “should,” “intend,” “believe,” and similar expressions. Although we believe the expectations reflected in these forward-looking statements are reasonable, such statements are inherently subject to risk and we can give no assurances that our expectations will prove to be correct. Actual results could differ from those described in this report because of numerous factors, many of which are beyond our control. These factors include, without limitation, those described under Item 1A “Risk Factors.” We undertake no obligation to update these forward-looking statements to reflect events or circumstances after the date of this report or to